Q3 2024 |
8 |
$169M |
+$1.67M |
-$19.7M |
-$18M |
MGNI, CGNT, MCHX, FEIM, BCOV
|
13F-HR |
11/13/2024, 04:35 PM |
Q2 2024 |
8 |
$180M |
+$227K |
-$25.5M |
-$25.3M |
MGNI, CGNT, MCHX, FEIM, BCOV
|
13F-HR |
8/13/2024, 01:03 PM |
Q1 2024 |
8 |
$194M |
+$8.98M |
-$65.7M |
-$56.7M |
MGNI, CGNT, FEIM, MCHX, BCOV
|
13F-HR |
5/14/2024, 05:52 PM |
Q4 2023 |
8 |
$232M |
+$139K |
-$11.5M |
-$11.4M |
MGNI, HAYN, CGNT, FEIM, MCHX
|
13F-HR |
2/13/2024, 05:43 PM |
Q3 2023 |
8 |
$206M |
+$1.76M |
-$63.9M |
-$62.1M |
MGNI, HAYN, CGNT, MCHX, BCOV
|
13F-HR |
11/13/2023, 05:46 PM |
Q2 2023 |
9 |
$329M |
+$487K |
-$13M |
-$12.5M |
MGNI, ABST, HAYN, CGNT, MCHX
|
13F-HR |
8/11/2023, 05:50 PM |
Q1 2023 |
9 |
$272M |
+$5.84M |
$0 |
+$5.84M |
MGNI, HAYN, ABST, BCOV, MCHX
|
13F-HR |
5/12/2023, 12:26 PM |
Q4 2022 |
9 |
$289M |
+$23.7M |
-$8.82M |
+$14.9M |
MGNI, ABST, HAYN, BCOV, MCHX
|
13F-HR |
2/13/2023, 04:02 PM |
Q3 2022 |
10 |
$253M |
+$23.5M |
-$60.5M |
-$37M |
ABST, MGNI, HAYN, BCOV, MCHX
|
13F-HR |
11/10/2022, 04:17 PM |
Q2 2022 |
12 |
$280M |
+$23M |
-$16.4M |
+$6.57M |
ABST, MGNI, HAYN, SREV, BCOV
|
13F-HR |
8/12/2022, 04:23 PM |
Q1 2022 |
13 |
$325M |
+$38.6M |
-$4.75M |
+$33.8M |
HAYN, MGNI, ABST, BCOV, MCHX
|
13F-HR |
5/13/2022, 05:07 PM |
Q4 2021 |
12 |
$325M |
$0 |
$0 |
|
MGNI, BCOV, ABST, HAYN, MCHX
|
13F-HR |
2/11/2022, 05:21 PM |
Q3 2021 |
12 |
$309M |
+$38M |
-$2.89M |
+$35.1M |
BCOV, MGNI, MCHX, HAYN, SREV
|
13F-HR |
11/12/2021, 04:38 PM |
Q2 2021 |
13 |
$305M |
+$32.7M |
-$4.14M |
+$28.6M |
BCOV, MGNI, MCHX, HAYN, SREV
|
13F-HR |
8/13/2021, 04:35 PM |
Q1 2021 |
11 |
$292M |
+$7.92M |
-$31.5M |
-$23.6M |
BCOV, MGNI, MCHX, SREV, HAYN
|
13F-HR |
5/14/2021, 10:55 AM |
Q4 2020 |
14 |
$270M |
+$40.9M |
-$94.3M |
-$53.4M |
BCOV, MGNI, SREV, MCHX, FEIM
|
13F-HR |
2/16/2021, 01:05 PM |
Q3 2020 |
13 |
$170M |
+$48.8M |
-$20.3M |
+$28.6M |
BCOV, MGNI, SREV, FEIM, MCHX
|
13F-HR |
11/16/2020, 01:00 PM |
Q2 2020 |
11 |
$136M |
+$40.7M |
-$14.3M |
+$26.4M |
BCOV, RUBI, SREV, HAYN, FEIM
|
13F-HR |
8/14/2020, 01:02 PM |
Q1 2020 |
13 |
$98.7M |
+$29.1M |
-$12.2M |
+$16.9M |
BCOV, FEIM, TLRA, MCHX, SREV
|
13F-HR |
5/15/2020, 02:00 PM |
Q4 2019 |
8 |
$128M |
$0 |
$0 |
|
TLRA, MCHX, BCOV, FEIM, SREV
|
13F-HR |
2/14/2020, 03:00 PM |